David Ross

49PUBLICATIONS
216CO-AUTHORS
Haematological tumoursGene and molecular therapyPredictive and prognostic markersMolecular targetsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|May 08, 2026
Single cell long read genotyping of transcripts reveals discrete mechanisms of clonal evolution in post-MPN AML.

|Apr 29, 2026
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study.

|Mar 05, 2026
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

Barbara Mora, Francesca Palandri, Paola Guglielmelli

|Feb 27, 2026
Phase 2 study of the lysine-specific demethylase 1 inhibitor bomedemstat for essential thrombocythemia.

Harinder Gill, Francesca Palandri, David M Ross

|Jan 05, 2026
Prediction of relapse after discontinuation of tyrosine kinase inhibitor treatment in CML.

David M Ross

|Sep 27, 2025
Lipid Storage and Therapy Resistance in Chronic Myeloid Leukaemia: A Novel Perspective on Targeting Metabolic Vulnerabilities.

Molly Tolland, David M Ross, Deborah White

Pageof 9

Frequent Collaborators

8 joint publications

Naranie Shanmuganathan

7 joint publications

Susan Branford

6 joint publications

Anna L Brown

5 joint publications

Christopher N Hahn